Emily Luisa Hill - Mar 31, 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Mar 31, 2022
Transactions value $
-$298,824
Form type
4
Date filed
4/1/2022, 04:20 PM
Previous filing
Feb 3, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$299K -7.91K -21.28% $37.78 29.3K Mar 31, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2022.
F2 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $37.30 to $38.20 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.